The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Client Partner Profiles

A Passion For Bringing New Drugs To Market – With the Best People

July 20, 2018
The pipeline of rare disease drugs in development at Ionis Pharmaceuticals has grown significantly in the last five years. And, with a robust pipeline combined with a commercialization strategy, including complex partnerships involving complicated deal structures, financial leadership roles are key to managing the process and bringing life-changing therapies to market. When Ionis needs to fill critical leadership roles, The Chase Group delivers outstanding people who are committed to the mission and the culture. Continue Reading →

The Right Stuff: Finding Executives Fit For the Big Challenges of Small Pharma

November 3, 2017
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, is small but mighty with 14 employees and a pipeline with potential. In a company where every person truly counts, Marinus trusts The Chase Group to attract executives who are comfortable with ambiguity and have the ambition to make a big impact. Continue Reading →

Exceptional Performance Requires Exceptional Talent

September 11, 2017
Genmab A/S is a biotechnology company specializing in the creation and development of antibody therapeutics for the treatment of cancer. When highly specialized executives must be recruited, Genmab relies on The Chase Group for their professionalism, tenacity, skill, and more than 25 years of life sciences recruitment success. Continue Reading →

Creating a Healthy Pipeline of Scientific Discovery, Drug Development – and People

July 31, 2017
Ionis Pharmaceuticals, a leader in drug discovery and development for rare diseases, has over 450 employees worldwide. When executives at Ionis need to fill crucial roles in various areas, they count on The Chase Group to deliver the best process, performance and people. Continue Reading →
© Copyright 1993-2018 The Chase Group; All Rights Reserved.